Strong, silent and stigmatized | Zendy

Iff Samuel | Zendy; Claussen Malte | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Strong, silent and stigmatized

Author(s) -

Iff Samuel,

Claussen Malte

Publication year - 2020

Publication title -

swiss sports and exercise medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.11

H-Index - 13

eISSN - 2673-2327

pISSN - 2297-8712

DOI - 10.34045/sems/2020/28

Subject(s) - elite , athletes , elite athletes , performance enhancement , substance abuse , anabolic androgenic steroids , public health , psychology , medicine , anabolism , advertising , psychiatry , physical therapy , political science , physical medicine and rehabilitation , business , nursing , endocrinology , politics , law

The global lifetime prevalence rate of all image and performance enhancing drugs (IPED) is unknown, however it is 6.4% in men an 1.6% in women for anabolic androgenic steroids [1]. IPED are widely used in the bodybuilding scene and have found a bigger audience through social media platforms. Risk groups for IPED use are young men, leisure athletes, general gym goers, elite athletes and bodybuilders. The main drivers for IPED use are increased muscularity and performance. Abuse of performance enhancing drugs in elite sports (doping) is well recognized, however IPED abuse is a public health problem that is often overlooked and should be addressed by the medical community.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research